A detailed history of First Commonwealth Financial Corp transactions in Abbott Laboratories stock. As of the latest transaction made, First Commonwealth Financial Corp holds 6,708 shares of ABT stock, worth $771,352. This represents 0.19% of its overall portfolio holdings.

Number of Shares
6,708
Previous 6,808 1.47%
Holding current value
$771,352
Previous $707,000 8.06%
% of portfolio
0.19%
Previous 0.19%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $10,007 - $11,813
-100 Reduced 1.47%
6,708 $764,000
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $76,151 - $85,004
756 Added 12.49%
6,808 $707,000
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $36,470 - $40,279
333 Added 5.82%
6,052 $687,000
Q2 2023

Aug 10, 2023

SELL
$100.78 - $112.29 $29,528 - $32,900
-293 Reduced 4.87%
5,719 $623,000
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $90,564 - $106,599
-935 Reduced 13.46%
6,012 $608,000
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $9,410 - $11,040
-99 Reduced 1.41%
6,947 $762,000
Q3 2022

Nov 09, 2022

BUY
$96.76 - $112.03 $9,579 - $11,090
99 Added 1.43%
7,046 $681,000
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $44,400 - $53,665
-435 Reduced 5.89%
6,947 $755,000
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $21,891 - $26,695
-192 Reduced 2.53%
7,382 $874,000
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $693 - $848
-6 Reduced 0.08%
7,574 $1.07 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $6,766 - $7,485
-58 Reduced 0.76%
7,580 $896,000
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $32,477 - $38,230
307 Added 4.19%
7,638 $885,000
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $77,276 - $91,043
-710 Reduced 8.83%
7,331 $879,000
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $3,675 - $4,004
35 Added 0.44%
8,041 $881,000
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $36,472 - $44,293
398 Added 5.23%
8,006 $872,000
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $19,142 - $24,500
250 Added 3.4%
7,608 $695,000
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $57,982 - $84,786
923 Added 14.34%
7,358 $581,000
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $4,583 - $4,969
56 Added 0.88%
6,435 $539,000
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $23,321 - $27,200
320 Added 5.28%
6,379 $537,000
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $18,938 - $22,897
-286 Reduced 4.51%
6,059 $484,000
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $6,621 - $7,501
-101 Reduced 1.57%
6,345 $458,000
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $15,993 - $19,293
-263 Reduced 3.92%
6,446 $473,000
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $31,433 - $34,692
-546 Reduced 7.53%
6,709 $409,000
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $89,806 - $101,537
-1,596 Reduced 18.03%
7,255 $435,000
Q4 2017

Feb 15, 2018

SELL
$53.68 - $57.47 $122,014 - $130,629
-2,273 Reduced 20.43%
8,851 $505,000
Q3 2017

Nov 13, 2017

SELL
$48.06 - $53.64 $141,392 - $157,808
-2,942 Reduced 20.92%
11,124 $594,000
Q2 2017

Aug 14, 2017

BUY
N/A
14,066
14,066 $684,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track First Commonwealth Financial Corp Portfolio

Follow First Commonwealth Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Commonwealth Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Commonwealth Financial Corp with notifications on news.